Kiniksa Pharmaceuticals International, plc
KNSA
Classement en actions
#2877
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Prix de l'action
$83.13
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$6.49B
Changement (1 jour)
4.59%
Changement (1 an)
113.97%
Pays
GB
Échange Kiniksa Pharmaceuticals International, plc (KNSA)
Catégorie
Healthcare
Nombre d'actions en circulation pour Kiniksa Pharmaceuticals International, plc (KNSA)
Nombre d'actions en circulation au June 2026: 77.58M
Selon les derniers rapports financiers et le cours de l'action de Kiniksa Pharmaceuticals International, plc, le nombre actuel d'actions en circulation est de 77.58M. À la fin de December 2023, l'entreprise avait 70.06M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Kiniksa Pharmaceuticals International, plc (KNSA) de 2016 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 77.58M | 8.62% |
| 2024 | 71.42M | 1.95% |
| 2023 | 70.06M | 0.98% |
| 2022 | 69.38M | 1.17% |
| 2021 | 68.58M | 10.89% |
| 2020 | 61.84M | 14.42% |
| 2019 | 54.05M | 82.92% |
| 2018 | 29.55M | -8.99% |
| 2017 | 32.47M | 0.00% |
| 2016 | 32.47M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 445.06M | 473.70% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 105.38M | 35.83% |
US
|
